文献速递角膜与眼表疾病

T细胞来源的粒细胞-巨噬细胞集落刺激因子通过促进CD11b+髓系细胞成熟与迁移参与干眼病发病

T Cell-Derived Granulocyte-Macrophage Colony-Stimulating Factor Contributes to Dry Eye Disease Pathogenesis by Promoting CD11b+ Myeloid Cell Maturation and Migration.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2017-01-01

研究在小鼠干眼病模型中观察T细胞来源的粒细胞-巨噬细胞集落刺激因子(GM-CSF)对CD11b+髓系细胞的作用。结果显示干眼病眼表GM-CSF显著上调、引流淋巴结中产GM-CSF的Th17细胞频率显著增加;体外中和CD4+ T细胞来源GM-CSF可抑制CD11b+细胞主要组织相容性复合体II类表达及迁移;局部中和GM-CSF可抑制CD11b+细胞成熟与迁移及Th17细胞诱导,并减轻临床体征。结论认为Th17细胞来源GM-CSF通过促进CD11b+细胞活化及向眼表迁移参与干眼病发病。

要点

  • 干眼病小鼠眼表GM-CSF显著上调,引流淋巴结产GM-CSF的Th17细胞频率显著增加。
  • 体外中和干眼病小鼠CD4+ T细胞来源GM-CSF可抑制CD11b+细胞MHC II类表达及迁移。
  • 局部中和GM-CSF可抑制CD11b+细胞成熟、迁移及Th17细胞诱导,并减轻临床体征。

核心结论

  • T helper 17细胞来源的GM-CSF通过促进CD11b+细胞活化及向眼表迁移参与干眼病发病。

研究设计与样本

  • 研究采用小鼠干眼病模型,使用定量实时PCR和ELISA检测眼表GM-CSF表达,用流式细胞术计数产GM-CSF的Th17细胞。
  • 研究在体内局部使用GM-CSF中和抗体,并在体外培养系统中评估GM-CSF在募集和成熟CD11b+细胞中的作用。
  • 局部给予GM-CSF中和抗体后评估临床疾病严重程度。

主要发现

  • 干眼病中眼表GM-CSF显著上调,引流淋巴结中产GM-CSF的Th17细胞频率显著增加。
  • 体外中和来自干眼病小鼠CD4+ T细胞的GM-CSF可抑制CD11b+细胞的主要组织相容性复合体II类表达及CD11b+细胞迁移。
  • 在小鼠干眼病模型中局部中和GM-CSF可抑制CD11b+细胞成熟与迁移以及Th17细胞诱导,并减轻临床体征。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Growing evidence suggests that granulocyte-macrophage colony-stimulating factor (GM-CSF) contributes to T helper 17 (Th17) cell-associated immunoinflammatory diseases. The purpose of this study was to evaluate the effect of T cell-derived GM-CSF on CD11b+ myeloid cell function in dry eye disease (DED). METHODS: In a murine model of DED, quantitative real-time PCR and ELISA were used to measure GM-CSF expression at the ocular surface, and flow cytometry was used to enumerate GM-CSF producing Th17 cells. A granulocyte-macrophage colony-stimulating factor neutralizing antibody was used topically in vivo and in an in vitro culture system to evaluate the role of GM-CSF in recruiting and maturing CD11b+ cells. Clinical disease severity was evaluated after topical administration of GM-CSF neutralizing antibody. RESULTS: In dry eye disease, GM-CSF is significantly upregulated at the ocular surface and the frequency of GM-CSF producing Th17 cells is significantly increased in the draining lymph nodes. In vitro neutralization of GM-CSF from CD4+ T cells derived from DED mice suppresses major histocompatibility complex II expression by CD11b+ cells and CD11b+ cell migration. Topical neutralization of GM-CSF in a murine model of DED suppresses CD11b+ maturation and migration, as well as Th17 cell induction, yielding a reduction in clinical signs of disease. CONCLUSIONS: T helper 17 cell-derived GM-CSF contributes to DED pathogenesis by promoting CD11b+ cell activation and migration to the ocular surface.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Dohlman TH, Ding J, Dana R, et al. T Cell-Derived Granulocyte-Macrophage Colony-Stimulating Factor Contributes to Dry Eye Disease Pathogenesis by Promoting CD11b+ Myeloid Cell Maturation and Migration. Invest Ophthalmol Vis Sci. 2017. PMID: 28241321. doi:10.1167/iovs.16-20789

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。